Skip to Main Content

Paper Details

Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.
Eur Respir J
40
2022
Angiotensin-converting enzyme, COVID, COVID-19, cancer, chronic liver disease, coronary heart disease, dementia, obstructive pulmonary disease, obstructive sleep apnea, patients, peripheral arterial disease, pharyngalgia, prognostic, rheumatological disease, venous thromboembolism
Author NameAffiliation
Karel G M MoonsJulius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University
Karel G M MoonsUniversity Medical Centre Utrecht, Utrecht University
Evangelos EvangelouUniversity of Ioannina Medical School
Evangelos EvangelouSchool of Public Health, Imperial College London
Evangelos EvangelouInstitute of Biosciences, University Research Center of Ioannina
Evangelos EvangelouUniversity of Ioannina Medical School
Evangelos EvangelouSchool of Public Health, Imperial College London
Evangelos EvangelouInstitute of Biosciences, University Research Center of Ioannina
  • 1 - 8

Datasets

Dataset
Description
Source Link
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
PubMedCitations and abstracts of biomedical literatureLink
Release 1.2